Presentation ACC 2019

Primary Results of the GLOBAL LEADERS Adjudication Sub-StudY (GLASSY)

Presenter: Marco Valgimigli

March 18, 2019

REGISTER for free or LOG IN to view this content

Ticagrelor Monotherapy Beyond One Month Versus Conventional Therapy On Adjudicated Ischemic And Bleeding Endpoints Following Drug Eluting Sent Implantation. Primary Results of the GLOBAL LEADERS Adjudication Sub-StudY (GLASSY)

Clinical Cardiology

Clinical Pharma

Presentation

ACC 2019

Ticagrelor

GLASSY

GLOBAL LEADERS

Up Next

Presentation ACC 2019

1-Year Outcomes from the CardioMEMS Post-Approval Study

Presenter: David M. Shavelle

March 18, 2019

More slides +

Presentation ACC 2019

First Randomized Human Experience with a Ticagrelor Reversal Agent

Presenter: Deepak L. Bhatt

March 18, 2019

Presentation ACC 2019

Health Status after Transcatheter Mitral- Valve Repair in Patients with Heart Failure and Secondary Mitral Regurgitation: Results from the COAPT Trial

Presenter: Suzanne V. Arnold

March 18, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.